1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships
Tóm tắt
Từ khóa
Tài liệu tham khảo
Govindarajan, 2018, Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics, Eur. J. Med. Chem., 143, 1208, 10.1016/j.ejmech.2017.10.015
Montana, 2019, Antitumoral activity of quinoxaline derivatives: a systematic review, Eur. J. Med. Chem., 163, 136, 10.1016/j.ejmech.2018.11.059
Islam, 2019, The potential role tubeimosides in cancer prevention and treatment, Eur. J. Med. Chem., 162, 109, 10.1016/j.ejmech.2018.11.001
Zhang, 2019, Tetrazole hybrids with potential anticancer activity, Eur. J. Med. Chem., 178, 341, 10.1016/j.ejmech.2019.05.071
Ammar, 2018, Recent advances of RAF (rapidly accelerated fibrosarcoma) inhibitors as anti-cancer agents, Eur. J. Med. Chem., 158, 144, 10.1016/j.ejmech.2018.09.005
Gao, 2019, Quinolone hybrids and their anti-cancer activities: an overview, Eur. J. Med. Chem., 165, 59, 10.1016/j.ejmech.2019.01.017
Zhuang, 2019, Small molecule-drug conjugates: a novel strategy for cancer targeted treatment, Eur. J. Med. Chem., 163, 883, 10.1016/j.ejmech.2018.12.035
Zhang, 2019, Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids, Eur. J. Med. Chem., 168, 357, 10.1016/j.ejmech.2019.02.055
Dheer, 2017, Medicinal attributes of 1,2,3-triazoles: current developments, Bioorg. Chem., 71, 30, 10.1016/j.bioorg.2017.01.010
Chu, 2019, Triazole derivatives and their antiplasmodial and antimalarial activities, Eur. J. Med. Chem., 166, 206, 10.1016/j.ejmech.2019.01.047
Kalaria, 2018, A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery, Eur. J. Med. Chem., 158, 917, 10.1016/j.ejmech.2018.08.040
Emami, 2019, Current advances of triazole alcohols derived from fluconazole: design, in vitro and in silico studies, Eur. J. Med. Chem., 170, 173, 10.1016/j.ejmech.2019.03.020
Castelli, 2017, Novel antifungal agents: a patent review (2013-present), Expert Opin. Ther. Pat., 27, 415, 10.1080/13543776.2017.1261113
Tian, 2018, Targeting the entrance channel of NNIBP: discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus, Eur. J. Med. Chem., 151, 339, 10.1016/j.ejmech.2018.03.059
Kaoukabi, 2018, Dihydropyrimidinone/1,2,3-triazole hybrid molecules: synthesis and anti-varicella-zoster virus (VZV) evaluation, Eur. J. Med. Chem., 155, 772, 10.1016/j.ejmech.2018.06.028
Zhang, 2017, Triazole derivatives and their anti-tubercular activity, Eur. J. Med. Chem., 138, 501, 10.1016/j.ejmech.2017.06.051
Lal, 2018, Recent advancements in 1,4-disubstituted 1H-1,2,3-triazoles as potential anticancer agents, Anti Cancer Agents Med. Chem., 18, 21, 10.2174/1871520616666160811113531
Akhtar, 2017, Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities, Eur. J. Med. Chem., 125, 143, 10.1016/j.ejmech.2016.09.023
Meunier, 2008, Hybrid molecules with a dual mode of action: dream or reality?, Acc. Chem. Res., 41, 69, 10.1021/ar7000843
Mishra, 2016, Hybrids molecules: the privileged scaffolds for various pharmaceuticals, Eur. J. Med. Chem., 124, 500, 10.1016/j.ejmech.2016.08.039
Hu, 2017, 4-Quinolone hybrids and their antibacterial activities, Eur. J. Med. Chem., 141, 335, 10.1016/j.ejmech.2017.09.050
Xu, 2017, Isatin hybrids and their anti-tuberculosis activity, Chin. Chem. Lett., 28, 159, 10.1016/j.cclet.2016.07.032
Tu, 2016, Artemisinin-a gift from traditional Chinese medicine to the world (Nobel lecture), Angew. Chem., Int. Ed. Engl., 55, 10210, 10.1002/anie.201601967
Kumari, 2019, Current scenario of artemisinin and its analogues for antimalarial activity, Eur. J. Med. Chem., 163, 804, 10.1016/j.ejmech.2018.12.007
Wang, 2019, A temporizing solution to artemisinin resistance, N. Engl. J. Med., 380, 2087, 10.1056/NEJMp1901233
Lam, 2019, Artemisinin and its derivatives: a potential treatment for leukemia, Anti Canccer Drugs, 30, 1, 10.1097/CAD.0000000000000697
Wong, 2017, Artemisinin as an anticancer drug: recent advances in target profiling and mechanisms of action, Med. Res. Rev., 37, 1492, 10.1002/med.21446
Liu, 2019, Biological activities of artemisinin derivatives beyond malaria, Curr. Top. Med. Chem., 19, 205, 10.2174/1568026619666190122144217
Binh, 2016, Synthesis and in vitro cytotoxic evaluation of new triazole derivatives based on artemisinin via click chemistry, Med. Chem. Res., 25, 738, 10.1007/s00044-016-1524-z
Kapkoti, 2018, Synthesis of novel 1,2,3-triazole based artemisinin derivatives and their antiproliferative activity, New J. Chem., 42, 5918, 10.1039/C7NJ04271J
Jana, 2017, Synthesis and anticancer activity of novel aza-artemisinin derivatives, Bioorg. Med. Chem., 25, 3671, 10.1016/j.bmc.2017.04.041
Li, 2013, Thiadiazole-A promising structure in medicinal chemistry, ChemMedChem, 8, 27, 10.1002/cmdc.201200355
Alianadi, 2016, 1,3,4-Thiadiazole based anticancer agents, Anti Cancer Agents Med. Chem., 16, 1301, 10.2174/1871520616666160628100936
Zhang, 2019, 1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents, Eur. J. Med. Chem., 174, 1, 10.1016/j.ejmech.2019.04.033
Gao, 2019, Antibacterial activity study of 1,2,4-triazole derivatives, Eur. J. Med. Chem., 173, 274, 10.1016/j.ejmech.2019.04.043
Chauhan, 2019, Synthesis of fluorescent binaphthyl amines that bind c-MYC G-Quadruplex DNA and repress c-MYC expression, J. Med. Chem., 59, 7275, 10.1021/acs.jmedchem.6b00328
Debnath, 2017, Preferential targeting of i-motifs and Gquadruplexes by small molecules, Chem. Sci., 8, 7448, 10.1039/C7SC02693E
Chauhan, 2016, Selective recognition of c-MYC G-quadruplex DNA using prolinamide derivatives, Org. Biomol. Chem., 14, 5761, 10.1039/C6OB00177G
Altamimi, 2018, Symmetric molecules with 1,4-triazole moieties as potent inhibitors of tumour-associated lactate dehydrogenase-A, J. Enzym. Inhib. Med. Chem., 33, 147, 10.1080/14756366.2017.1404593
Abd-Rabou, 2018, Synthesis, molecular docking, and evaluation of novel bivalent pyrazolinyl-1,2,3-triazoles as potential VEGFR TK inhibitors and anti-cancer agents, Chem. Pap., 72, 2225, 10.1007/s11696-018-0451-5
da Silva, 2019, Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells, Bioorg. Chem., 83, 87, 10.1016/j.bioorg.2018.10.003
Kumar, 2018, Design and synthesis of fluorescent symmetric bis-triazolylated-1,4-dihydropyridines as potent antibreast cancer agents, Synth. Commun., 48, 778, 10.1080/00397911.2017.1422521
Pertino, 2015, Synthesis, antiproliferative and antifungal activities of 1,2,3-triazole-substituted carnosic acid and carnosol derivatives, Molecules, 20, 8666, 10.3390/molecules20058666
Kheder, 2016, In vitro antimicrobial, anti-liver cancer evaluation of some novel bis-cyanocrylamide and bis-azoles derivatives, Int. J. Pharm. Sci., 8, 420
Chojnacki, 2017, In vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives, Bioorg. Chem., 72, 1, 10.1016/j.bioorg.2017.02.017
Zheng, 2016, 1,2,3-Triazole-dithiocarbamate hybrids, a group of novel cell active SIRT1 inhibitors, Cell. Physiol. Biochem., 38, 185, 10.1159/000438620
Wu, 2018, Synthesis and structure-activity relationship studies of MI-2 analogues as MALT1 inhibitors, Bioorg. Med. Chem., 26, 3321, 10.1016/j.bmc.2018.04.059
Fan, 2018, Recent advances of imidazole-containing derivatives as anti-tubercular agents, Eur. J. Med. Chem., 150, 347, 10.1016/j.ejmech.2018.03.016
Niinivehmas, 2018, Blocking oestradiol synthesis pathways with potent and selective coumarin derivatives, J. Enzym. Inhib. Med. Chem., 33, 743, 10.1080/14756366.2018.1452919
Bistrovic, 2018, Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer, Eur. J. Med. Chem., 143, 1616, 10.1016/j.ejmech.2017.10.061
Sahay, 2017, Synthesis of new 1,2,3-triazole linked benzimidazole molecules as anti-proliferative agents, Synth. Commun., 47, 825, 10.1080/00397911.2017.1289412
Shaik, 2017, Design and synthesis of imidazo[2,1-b]thiazole linked triazole conjugates: microtubule-destabilizing agents, Eur. J. Med. Chem., 126, 36, 10.1016/j.ejmech.2016.09.060
Sayeed, 2018, Imidazopyridine linked triazoles as tubulin inhibitors, effectively triggering apoptosis in lung cancer cell line, Bioorg. Chem., 80, 714, 10.1016/j.bioorg.2018.07.026
Abdallah, 2015, Dyeing applications and anticancer evaluations of benzimidazole derivatives: novel synthesis of thiophene, triazole and pyrimidine derivatives. Egypt, J. Chem., 58, 699
Zhang, 2018, Recent advance in oxazole-based medicinal chemistry, Eur. J. Med. Chem., 144, 444, 10.1016/j.ejmech.2017.12.044
Kaur, 2018, Therapeutic potential of oxazole scaffold: a patent review (2006-2017), Expert Opin. Ther. Pat., 28, 783, 10.1080/13543776.2018.1526280
Valdomir, 2018, Oxa/thiazole-tetrahydropyran triazole-linked hybrids with selective antiproliferative activity against human tumour cells, New J. Chem., 42, 13784, 10.1039/C8NJ02388C
Srivastava, 2015, One-pot sequential alkynylation and cycloaddition: regioselective construction and biological evaluation of novel benzoxazole-triazole derivatives, ACS Comb. Sci., 17, 39, 10.1021/co500135z
Najafi, 2015, Synthesis and in vitro cytotoxic activity of novel triazole-isoxazole derivatives, J. Heterocycl. Chem., 52, 1743, 10.1002/jhet.2273
Ashwini, 2015, Synthesis of 1,2-benzisoxazole tethered 1,2,3-triazoles that exhibit anticancer activity in acute myeloid leukemia cell lines by inhibiting histone deacetylases, and inducing p21 and tubulin acetylation, Bioorg. Med. Chem., 23, 6157, 10.1016/j.bmc.2015.07.069
Madhavilatha, 2018, Synthesis and in vitro anticancer activity of novel 1,3,4-oxadiazole-linked 1,2,3-triazole/isoxazole hybrids, J. Heterocycl. Chem., 55, 863, 10.1002/jhet.3110
Xu, 2017, Recent advances of pyrazole-containing derivatives as anti-tubercular agents, Eur. J. Med. Chem., 139, 429, 10.1016/j.ejmech.2017.07.059
Ganguly, 2017, Therapeutic outlook of pyrazole analogs: a mini review, Mini Rev. Med. Chem., 17, 959, 10.2174/1389557516666151120115302
Liu, 2013, Pyrazole derivatives as antitumor, anti-inflammatory and antibacterial agents, Mini Rev. Med. Chem., 13, 1957, 10.2174/13895575113139990078
Chauhan, 2014, Anticancer activity of pyrazole via different biological mechanisms, Synth. Commun., 44, 1333, 10.1080/00397911.2013.837186
Reddy, 2015, Synthesis and biological evaluation of pyrazolo-triazole hybrids as cytotoxic and apoptosis inducing agents, Org. Biomol. Chem., 13, 10136, 10.1039/C5OB00842E
Reddy, 2016, Design, synthesis and biological evaluation of N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)-1,3-diphenyl-1H-pyrazole-4-carboxamides as CDK1/Cdc2 inhibitors, Eur. J. Med. Chem., 122, 164, 10.1016/j.ejmech.2016.06.011
Amin, 2017, Possible binding mode analysis of pyrazolo-triazole hybrids as potential anticancer agents through validated molecular docking and 3D-QSAR modeling approaches, Lett. Drug Des. Discov., 14, 515, 10.2174/1570180813666160916153017
Manjunatha, 2016, 1,2,3-Triazolyl pyrazole derivatives as anti-cancer agents: biological evaluation and molecular docking, Der Pharma Chem., 8, 200
Khan, 2019, Unveiling novel diphenyl-1H-pyrazole based acrylates tethered to 1,2,3-triazole as promising apoptosis inducing cytotoxic and anti-inflammatory agents, Bioorg. Chem., 87, 667, 10.1016/j.bioorg.2019.03.071
Madhavilatha, 2017, Synthesis of 1,2,3-triazole and isoxazole-linked pyrazole hybrids and their cytotoxic activity, Med. Chem. Res., 26, 1753, 10.1007/s00044-017-1884-z
Sarangi, 2016, Thiazoles as potent anticancer agents: a review, Indian Drugs, 53, 5, 10.53879/id.53.11.10755
Aouad, 2018, Design, synthesis and anticancer screening of novel benzothiazole-piperazine-1,2,3-triazole hybrids, Molecules, 23, e2788, 10.3390/molecules23112788
Kumbhare, 2015, Synthesis and anticancer evaluation of novel triazole linked N-(pyrimidin-2-yl)benzo[d]thiazol-2-amine derivatives as inhibitors of cell survival proteins and inducers of apoptosis in MCF-7 breast cancer cells, Bioorg. Med. Chem. Lett, 25, 654, 10.1016/j.bmcl.2014.11.083
Shaik, 2017, Design and synthesis of 1,2,3-triazolo linked benzo[d]imidazo[2,1-b]thiazole conjugates as tubulin polymerization inhibitors, Bioorg. Med. Chem., 25, 3285, 10.1016/j.bmc.2017.04.013
Nagavelli, 2016, Synthesis, cytotoxic and antibacterial activities of 6-bromobenzo[d]thiazol-2(3H)-one-[1,2,3]triazole hybrids, Org. Commun., 9, 32
Yadav, 2011, The role of chalcones in suppression of NF-κB-mediated inflammation and cancer, Int. Immunopharmacol., 11, 295, 10.1016/j.intimp.2010.12.006
Sharma, 2013, Heterocyclic chalcone analogues as potential anticancer agents, Anti Cancer Agents Med. Chem., 13, 422
Hussaini, 2016, Synthesis and biological evaluation of 1,2,3-triazole tethered pyrazoline and chalcone derivatives, Chem. Biol. Drug Des., 88, 97, 10.1111/cbdd.12738
Chinthala, 2015, Docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity, Eur. J. Med. Chem., 93, 564, 10.1016/j.ejmech.2015.02.027
Yadav, 2017, Green synthesis and anticancer potential of chalcone linked-1,2,3-triazoles, Eur. J. Med. Chem., 126, 944, 10.1016/j.ejmech.2016.11.030
Fu, 2016, Design, synthesis and antiproliferative activity studies of 1,2,3-triazole-chalcones, MedChemComm, 7, 1664, 10.1039/C6MD00169F
Hari, 2016, Green synthesis, characterization of novel 1,2,3-triazole-chalcone hybrids and evaluation of their antibacterial, antifungal and antiproliferation activity, Der Pharma Chem., 8, 275
Rashdan, 2018, Design, efficient synthesis, mechanism of reaction and antiproliferative activity against cancer and normal cell lines of a novel class of fused pyrimidine derivatives, Acta Pol. Pharm., 75, 679
Aneja, 2018, N-Substituted 1,2,3-triazolyl-appended indole-chalcone hybrids as potential DNA intercalators endowed with antioxidant and anticancer properties, ChemistrySelect, 3, 2638, 10.1002/slct.201702913
Thakur, 2015, Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies, Eur. J. Med. Chem., 101, 476, 10.1016/j.ejmech.2015.07.010
Dandriyal, 2016, Recent developments of C-4 substituted coumarin derivatives as anticancer agents, Eur. J. Med. Chem., 119, 141, 10.1016/j.ejmech.2016.03.087
Teillet, 2008, Flavonoids as RTK inhibitors and potential anticancer agents, Med. Res. Rev., 28, 715, 10.1002/med.20122
Maggioni, 2015, Flavonoids in oral cancer prevention and therapy, Eur. J. Cancer Prev., 24, 517, 10.1097/CEJ.0000000000000109
Fan, 2018, Coumarin-triazole hybrids and their biological activities, J. Heterocycl. Chem., 55, 791, 10.1002/jhet.3112
Kraljevic, 2016, In vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids, Eur. J. Med. Chem., 124, 794, 10.1016/j.ejmech.2016.08.062
Bistrovic, 2017, Synthesis of 4-aryl-1,2,3-triazolyl appended natural coumarin related compounds with antiproliferative, radical scavenging activities and intracellular ROS production modification, New J. Chem., 41, 7531, 10.1039/C7NJ01469D
An, 2018, Design, synthesis and biological evaluation of novel 4-substituted coumarin derivatives as antitumor agents, Molecules, 23, e2281, 10.3390/molecules23092281
Fu, 2019, Molecular diversity of trimethoxyphenyl-1,2,3-triazole hybrids as novel colchicine site tubulin polymerization inhibitors, Eur. J. Med. Chem., 165, 309, 10.1016/j.ejmech.2019.01.033
Farley, 2016, Evaluation of synthetic coumarins for antiausterity cytotoxicity against pancreatic cancers, Bioorg. Med. Chem. Lett, 26, 1471, 10.1016/j.bmcl.2016.01.054
Duan, 2013, Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents, Eur. J. Med. Chem., 62, 11, 10.1016/j.ejmech.2012.12.046
Sinha, 2016, Synthesis and cytotoxicity study of novel 3-(triazolyl)coumarins based fluorescent scaffolds, Bioorg. Med. Chem. Lett, 26, 5557, 10.1016/j.bmcl.2016.09.078
Shen, 2017, Design and synthesis of new triazoles linked to xanthotoxin for potent and highly selective anti-gastric cancer agents, Bioorg. Med. Chem. Lett, 27, 4871, 10.1016/j.bmcl.2017.09.040
Lipeeva, 2015, Synthesis of 1H-1,2,3-triazole linked aryl(arylamidomethyl)-dihydrofurocoumarin hybrids and analysis of their cytotoxicity, Eur. J. Med. Chem., 100, 119, 10.1016/j.ejmech.2015.05.016
Ansary, 2019, Regioselective synthesis, molecular descriptors of (1,5-disubstituted 1,2,3-triazolyl)coumarin/quinolone derivatives and their docking studies against cancer targets, ChemistrySelect, 4, 3486, 10.1002/slct.201900114
Reddy, 2014, Synthesis of novel 1,2,3-triazole/isoxazole functionalized 2H-chromene derivatives and their cytotoxic activity, Bioorg. Med. Chem. Lett, 24, 1661, 10.1016/j.bmcl.2014.02.069
Raj, 2017, “MCR-Click” synthesis of coumarin-tagged macrocycles with large Stokes shift values and cytotoxicity against human breast cancer cell line MCF-7, Tetrahedron Lett., 58, 2122, 10.1016/j.tetlet.2017.04.052
Chekir, 2018, Design, synthesis and biological evaluation of novel 1,2,3-triazole linked coumarinopyrazole conjugates as potent anticholinesterase, anti-5-lipoxygenase, anti-tyrosinase and anti-cancer agents, Bioorg. Chem., 80, 189, 10.1016/j.bioorg.2018.06.005
Sowjanya, 2017, Synthesis and antiproliferative activity of new 1,2,3-triazole/flavone hybrid heterocycles against human cancer cell lines, Russ. J. Gen. Chem., 87, 1864, 10.1134/S1070363217080357
Qi, 2019, Novel triazole analogs of apigenin-7-methyl ether exhibit potent antitumor activity against ovarian carcinoma cells via the induction of mitochondrial-mediated apoptosis, Exp. Ther. Med., 17, 1670
Wu, 2018, Discovery of novel negletein derivatives as potent anticancer agents for acute Myeloid Leukemia, Chem. Biol. Drug Des., 91, 924, 10.1111/cbdd.13159
Rao, 2018, Synthesis and biological evaluation of novel flavone/triazole/benzimidazole hybrids and flavone/isoxazole-annulated heterocycles as antiproliferative and antimycobacterial agents, Mol. Divers., 22, 803, 10.1007/s11030-018-9833-4
Mistry, 2017, Access to the substituted benzyl-1,2,3-triazolyl hesperetin derivatives expressing antioxidant and anticancer effects, Arab. J. Chem., 10, 157, 10.1016/j.arabjc.2015.10.004
Li, 2017, ‘Click chemistry’ synthesis of novel natural product-like caged Xanthones bearing a 1,2,3-triazole moiety with improved druglike properties as orally active antitumor agents, Molecules, 22, e1834, 10.3390/molecules22111834
Patil, 2012, Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents, Future Med. Chem., 4, 2085, 10.4155/fmc.12.141
Xu, 2017, Isatin hybrids and their anti-tuberculosis activity, Chin. Chem. Lett., 28, 159, 10.1016/j.cclet.2016.07.032
Penthala, 2015, Synthesis and anti-cancer screening of novel heterocyclic-(2H)-1,2,3-triazoles as potential anti-cancer agents, MedChemComm, 6, 1535, 10.1039/C5MD00219B
Narsimha, 2016, Indole-2-carboxylic acid derived mono and bis 1,4-disubstituted 1,2,3-triazoles: synthesis, characterization and evaluation of anticancer, antibacterial, and DNA-cleavage activities, Bioorg. Med. Chem. Lett, 26, 1639, 10.1016/j.bmcl.2016.01.055
Naaz, 2018, 1,2,3-Triazole tethered indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: their anti-proliferative & anti-inflammatory activity, Bioorg. Chem., 81, 1, 10.1016/j.bioorg.2018.07.029
Lolli, 2019, Bioisosteres of indomethacin as inhibitors of aldo-keto reductase 1C3 (AKR1C3), ACS Med. Chem. Lett., 10, 437, 10.1021/acsmedchemlett.8b00484
Kummari, 2017, Design and synthesis of 1,2,3-triazole-etodolac hybrids as potent anticancer molecules, RSC Adv., 7, 23680, 10.1039/C6RA28525B
Humphries-Bickley, 2017, Characterization of a dual Rac/Cdc42 inhibitor MBQ-167 in metastatic cancer, Mol. Cancer Ther., 16, 805, 10.1158/1535-7163.MCT-16-0442
Panathur, 2016, Synthesis of novel 5-[(1,2,3-triazol-4-yl)methyl]-1-methyl-3H-pyridazino[4,5-b]indol-4-one derivatives by click reaction and exploration of their anticancer activity, Med. Chem. Res., 25, 135, 10.1007/s00044-015-1473-y
Shankaraiah, 2016, Design and synthesis of C3-tethered 1,2,3-triazolo-β-carboline derivatives: anticancer activity, DNA-binding ability, viscosity and molecular modeling studies, Bioorg. Chem., 64, 42, 10.1016/j.bioorg.2015.11.005
Hu, 2017, Photodynamic therapy using indolines-fused-triazoles induces mitochondrial apoptosis in human non-melanoma BCC cells, Anticancer Res., 37, 5499
Yu, 2016, Design and synthesis of isatin/triazole conjugates that induce apoptosis and inhibit migration of MGC-803 cells, Eur. J. Med. Chem., 124, 350, 10.1016/j.ejmech.2016.08.065
Nagarsenkar, 2016, Synthesis and apoptosis inducing studies of triazole linked 3-benzylidene isatin derivatives, Eur. J. Med. Chem., 124, 782, 10.1016/j.ejmech.2016.09.009
Aneja, 2018, Design and development of isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis, Eur. J. Med. Chem., 163, 840, 10.1016/j.ejmech.2018.12.026
Senwar, 2015, Spirooxindole-derived morpholine-fused-1,2,3-triazoles: design, synthesis, cytotoxicity and apoptosis inducing studies, Eur. J. Med. Chem., 102, 413, 10.1016/j.ejmech.2015.08.017
Chavan, 2019, Click chemistry based multicomponent approach in the synthesis of spirochromenocarbazole tethered 1,2,3-triazoles as potential anticancer agents, Bioorg. Med., 85, 475, 10.1016/j.bioorg.2019.01.070
Lu, 2017, Design, combinatorial synthesis and biological evaluations of novel 3-amino-10-((1-aryl-1H-1,2,3-triazol-5-yl)methyl)-20-oxospiro[benzo[a]pyrano[2,3-c]phenazine-1,30-indoline]-2-carbonitrile antitumor hybrid molecules, Eur. J. Med. Chem., 135, 125, 10.1016/j.ejmech.2017.04.040
Jain, 2018, Design, synthesis and evaluation of 1H-1,2,3-triazol-4-yl-methyl tethered 3-pyrrolylisatins as potent anti-breast cancer agents, ChemistrySelect, 3, 5263, 10.1002/slct.201800420
Prachayasittikul, 2017, Roles of pyridine and pyrimidine derivatives as privileged scaffolds in anticancer agents, Mini Rev. Med. Chem., 17, 869, 10.2174/1389557516666160923125801
Goel, 2016, Imidazo[1,2-a]pyridines: promising drug candidate for antitumor therapy, Curr. Top. Med. Chem., 16, 3590, 10.2174/1568026616666160414122644
Akhtar, 2017, Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities, Eur. J. Med. Chem., 125, 143, 10.1016/j.ejmech.2016.09.023
Kamal, 2015, Synthesis of 2-anilinopyridyl-triazole conjugates as antimitotic agents, Org. Biomol. Chem., 13, 4879, 10.1039/C5OB00232J
Prasad, 2019, Synthesis and biological evaluation of 1-benzyl-N-(2-(phenylamino)pyridin-3-yl)-1H-1,2,3-triazole-4-carboxamides as antimitotic agents, Bioorg. Chem., 83, 535, 10.1016/j.bioorg.2018.11.002
Bai, 2016, Structure-based design of potent nicotinamide phosphoribosyltransferase inhibitors with promising in vitro and in vivo antitumor activities, J. Med. Chem., 59, 5766, 10.1021/acs.jmedchem.6b00324
Dong, 2017, Small molecule inhibitors simultaneously targeting cancer metabolism and epigenetics: discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) and histone deacetylase (HDAC) dual inhibitors, J. Med. Chem., 60, 7965, 10.1021/acs.jmedchem.7b00467
Travelli, 2017, Identification of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors endowed with antiproliferative and antiinflammatory activity, J. Med. Chem., 60, 1768, 10.1021/acs.jmedchem.6b01392
Theeramunkong, 2015, Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement, MedChemComm, 6, 1891, 10.1039/C5MD00261C
Ye, 2017, Synthesis and antitumor activity of triazole-containing sorafenib analogs, Molecules, 22, e1759, 10.3390/molecules22101759
Christodoulou, 2015, Click reaction as a tool to combine pharmacophores: the case of vismodegib, ChemPlusChem, 80, 938, 10.1002/cplu.201402435
Gilandoust, 2018, Synthesis, characterization and cytotoxicity studies of 1,2,3-triazoles and 1,2,4-triazolo[1,5-a]pyrimidines in human breast cancer cells, Bioorg. Med. Chem. Lett, 28, 2314, 10.1016/j.bmcl.2018.05.020
Hockey, 2016, A comparison of novel organoiridium(III) complexes and their ligands as a potential treatment for prostate cancer, Eur. J. Med. Chem., 109, 305, 10.1016/j.ejmech.2015.12.035
Li, 2016, Syntheses and biological evaluation of 1,2,3-triazole and 1,3,4-oxadiazole derivatives of imatinib, Bioorg. Med. Chem. Lett, 26, 1419, 10.1016/j.bmcl.2016.01.068
Tang, 2016, Discovery of novel pyrrolo[2,3-b]pyridine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors, Bioorg. Med. Chem. Lett, 26, 1680, 10.1016/j.bmcl.2016.02.059
Narva, 2016, Synthesis and biological evaluation of pyrrolo[2,3-b]pyridine analogues as antiproliferative agents and their interaction with calf thymus DNA, Eur. J. Med. Chem., 114, 220, 10.1016/j.ejmech.2016.02.059
Gilandoust, 2018, Synthesis, characterization and cytotoxicity studies of 1,2,3-triazoles and 1,2,4-triazolo[1,5-a]pyrimidines in human breast cancer cells, Bioorg. Med. Chem. Lett, 28, 2314, 10.1016/j.bmcl.2018.05.020
Steiner, 2016, Discovery of ‘click’ 1,2,3-triazolium salts as potential anticancer drugs, Radiol. Oncol., 50, 280, 10.1515/raon-2016-0027
Banda, 2016, Synthesis of novel 1,2,3-triazole/isoxazole-functionalized imidazo[4,5-b]pyridin-2(3H)-one derivatives, their antimicrobial and anticancer activity, J. Heterocycl. Chem., 53, 1168, 10.1002/jhet.2370
Cherukupalli, 2017, An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold, Eur. J. Med. Chem., 126, 298, 10.1016/j.ejmech.2016.11.019
Wang, 2018, Discovery of novel 2,4-diarylaminopyrimidine analogues as ALK and ROS1 dual inhibitors to overcome crizotinib-resistant mutants including G1202R, Eur. J. Med. Chem., 143, 123, 10.1016/j.ejmech.2017.11.008
Wang, 2018, Exploration of 1,2,3-triazole-pyrimidine hybrids as potent reversal agents against ABCB1-mediated multidrug resistance, Eur. J. Med. Chem., 143, 1535, 10.1016/j.ejmech.2017.10.041
Geng, 2018, Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety, Eur. J. Med. Chem., 146, 147, 10.1016/j.ejmech.2018.01.031
Li, 2016, Design, synthesis and biological evaluation of [1,2,3]triazolo[4,5-d]pyrimidine derivatives possessing a hydrazone moiety as antiproliferative agents, Eur. J. Med. Chem., 124, 967, 10.1016/j.ejmech.2016.10.022
Wang, 2018, Discovery of thinopyrimidine-triazole conjugates as c-Met targeting and apoptosis inducing agents, Bioorg. Chem., 77, 370, 10.1016/j.bioorg.2018.01.037
Lee, 2016, The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3, Bioorg. Med. Chem., 24, 5036, 10.1016/j.bmc.2016.08.008
Bistrovic, 2018, Small molecule purine and pseudopurine derivatives: synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549, J. Enzym. Inhib. Med. Chem., 33, 271, 10.1080/14756366.2017.1414807
Kumar, 2016, Synthesis of novel triazole/isoxazole functionalized 7-(trifluoromethyl)pyrido[2,3-d]pyrimidine derivatives as promising anticancer and antibacterial agents, Bioorg. Med. Chem. Lett, 26, 2927, 10.1016/j.bmcl.2016.04.038
Vasilyeva, 2017, Conjugates of phosphorylated zalcitabine and lamivudine with SiO2 nanoparticles: synthesis by CuAAC click chemistry and preliminary assessment of anti-HIV and antiproliferative activity, Bioorg. Med. Chem., 25, 1696, 10.1016/j.bmc.2017.01.038
Babic, 2017, Cytostatic and antibacterial evaluations of novel 1,2,3-triazolyl-tagged pyrimidine and furo[2,3-d]pyrimidine derivatives, Croat. Chem. Acta, 90, 197
Gregoric, 2017, Novel pyrimidine-2,4-dione-1,2,3-triazole and furo[2,3-d]pyrimidine-2-one-1,2,3-triazole hybrids as potential anti-cancer agents: synthesis, computational and X-ray analysis and biological evaluation, Eur. J. Med. Chem., 125, 1247, 10.1016/j.ejmech.2016.11.028
Allam, 2018, Synthesis of pyrazolo[3,4-d]pyrimidin-4(5H)-ones tethered to 1,2,3-triazoles and their evaluation as potential anticancer agents, Eur. J. Med. Chem., 156, 43, 10.1016/j.ejmech.2018.06.055
Ruddarraju, 2017, Design, synthesis, anticancer activity and docking studies of theophylline containing 1,2,3-triazoles with variant amide derivatives, MedChemComm, 8, 176, 10.1039/C6MD00479B
Kumar, 2018, Biological evaluation, and molecular docking studies of novel 1,2,3-triazole tagged 5-[(1H-indol-3-yl)methylene]pyrimidine-2,4,6(1H,3H,5H)trione derivatives, Russ. J. Gen. Chem., 88, 587, 10.1134/S1070363218030313
Montgomery, 2017, Transition state-based ST6Gal I inhibitors: mimicking the phosphodiester linkage with a triazole or carbamate through an enthalpy-entropy compensation, Sci. Rep., 7, 14428, 10.1038/s41598-017-14560-0
Lu, 2019, Design, synthesis and biological evaluation of novel uracil derivatives bearing 1, 2, 3-triazole moiety as thymidylate synthase (TS) inhibitors and as potential antitumor drugs, Eur. J. Med. Chem., 171, 282, 10.1016/j.ejmech.2019.03.047
Hameed, 2018, Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011-2016), Expert Opin. Ther. Pat., 28, 281, 10.1080/13543776.2018.1432596
Li, 2016, Research progress in quinazoline derivatives with anticancer activity, Chin. Pharmaceut. J., 51, 867
Rave, 2015, Quinazoline derivatives as anticancer drugs: a patent review (2011-present), Expert Opin. Ther. Pat., 25, 789, 10.1517/13543776.2015.1039512
Banerji, 2018, Synthesis of triazole-substituted quinazoline hybrids for anticancer activity and a lead compound as the EGFR blocker and ROS inducer agent, ACS Omega, 3, 16134, 10.1021/acsomega.8b01960
Le-Nhat-Thuy, 2018, Design, synthesis and evaluation of novel hybrids between 4-anilinoquinazolines and substituted triazoles as potent cytotoxic agents, Bioorg. Med. Chem. Lett, 28, 3741, 10.1016/j.bmcl.2018.10.016
Song, 2017, Cytotoxic activity evaluation of novel 1,2,3-triazole linked quinazoline derivatives, Chin. J. Chem., 35, 1633, 10.1002/cjoc.201700005
Shi, 2018, Design and synthesis of novel triazolo-lapatinib hybrids as inhibitors of breast cancer cells, Med. Chem. Res., 27, 2437, 10.1007/s00044-018-2247-0
Venkatesh, 2015, Luotonin-A based quinazolinones cause apoptosis and senescence via HDAC inhibition and activation of tumor suppressor proteins in HeLa cells, Eur. J. Med. Chem., 94, 87, 10.1016/j.ejmech.2015.02.057
Vasu, 2018, 2-((1H-1,2,3-Triazol-1-yl)methyl)-3-phenylquinazolin-4(3H)-ones: design, synthesis and evaluation as anti-cancer agents, Curr. Bioact. Compd., 14, 254, 10.2174/1573407213666170329131557
Safavi, 2018, Novel quinazolin-4(3H)-one linked to 1,2,3-triazoles: synthesis and anticancer activity, Chem. Biol. Drug Des., 92, 1373, 10.1111/cbdd.13203
Batalha, 2016, Quinolone in the search for new anticancer agents, Curr. Pharmaceut. Des., 22, 6009, 10.2174/1381612822666160715115025
Xu, 2018, Quinolone-triazole hybrids and their biological activities, J. Heterocycl. Chem., 55, 1854, 10.1002/jhet.3234
Boratynski, 2018, Triazole biheterocycles from Cinchona alkaloids: coordination and antiproliferative properties, ChemistrySelect, 3, 9368, 10.1002/slct.201801810
Nordstrom, 2015, Discovery of autophagy inhibitors with antiproliferative activity in lung and pancreatic cancer cells, ACS Med. Chem. Lett., 6, 134, 10.1021/ml500348p
Begnini, 2017, Apoptosis induction by 7-chloroquinoline-1,2,3-triazoyl carboxamides in triple negative breast cancer cells, Biomed. Pharmacother., 91, 510, 10.1016/j.biopha.2017.04.098
Dasari, 2019, Design, synthesis and molecular modeling of nonsteroidal anti-inflammatory drugs tagged substituted 1,2,3-triazole derivatives and evaluation of their biological activities, J. Heterocycl. Chem., 56, 1318, 10.1002/jhet.3503
Irfan, 2016, Biological activities and in silico physico-chemical properties of 1,2,3-triazoles derived from natural bioactive alcohols, Anti-Infect. Agents, 14, 126, 10.2174/2211352514666160606115200
Korcz, 2018, Synthesis, structure, chemical stability, and in vitro cytotoxic properties of novel quinoline-3-carbaldehyde hydrazones bearing a 1,2,4-triazole or benzotriazole moiety, Molecules, 23, e1497, 10.3390/molecules23061497
Zhao, 2017, Identification of 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimization, Eur. J. Med. Chem., 134, 147, 10.1016/j.ejmech.2017.03.085
Madadi, 2015, Synthesis and biological evaluation of novel 4,5-disubstituted 2H-1,2,3-triazoles as cis-constrained analogues of combretastatin A-4, Eur. J. Med. Chem., 103, 123, 10.1016/j.ejmech.2015.08.041
Liu, 2016, Discovery of a novel 6,7-disubstituted-4-(2-fluorophenoxy)quinolines bearing 1,2,3-triazole-4-carboxamide moiety as potent c-Met kinase inhibitors, Eur. J. Med. Chem., 119, 96, 10.1016/j.ejmech.2016.04.035
Zeng, 2017, Discovery of novel 11-triazole substituted benzofuro[3,2-b]quinolone derivatives as c-myc G-Quadruplex specific stabilizers via click chemistry, J. Med. Chem., 60, 5407, 10.1021/acs.jmedchem.7b00016
Theeramunkong, 2016, Synthesis and biological evaluation of simplified analogs of lophocladine B as potential antitumor agents, Med. Chem. Res., 25, 2959, 10.1007/s00044-016-1717-5
Jin, 2015, Novel triazolyl berberine derivatives prepared via CuAAC click chemistry: synthesis, anticancer activity and structure-activity relationships, Anti Cancer Agents Med. Chem., 15, 89, 10.2174/1871520614666141203142012
Liu, 2015, 6,7-Dimethoxy-2-{2-[4-(1H-1,2,3-triazol-1-yl)phenyl]ethyl}-1,2,3,4-tetrahydroisoquinolines as superior reversal agents for P-glycoprotein-mediated multidrug resistance, ChemMedChem, 10, 336, 10.1002/cmdc.201402463
Arabiyat, 2017, Antilipase and antiproliferative activities of novel fluoroquinolones and triazolofluoroquinolones, Chem. Biol. Drug Des., 90, 1282, 10.1111/cbdd.13049
Pirali, 2017, Identification of a potent phosphoinositide 3-kinase pan inhibitor displaying a strategic carboxylic acid group and development of its prodrugs, ChemMedChem, 12, 1542, 10.1002/cmdc.201700340
Mohammadi-Khanaposhtani, 2015, Design, synthesis, in vitro cytotoxic activity evaluation, and apoptosis-induction study of new 9(10H)-acridinone-1,2,3-triazoles, Mol. Divers., 19, 787, 10.1007/s11030-015-9616-0
Thi, 2016, Synthesis and cytotoxic evaluation of novel indenoisoquinoline-substituted triazole hybrids, Bioorg. Med. Chem. Lett, 26, 3652, 10.1016/j.bmcl.2016.05.092
Siatis, 2010, Quinones and quinone derivatives as pharmaceutical agents for the treatment of cancer recent advances in synthesis and evaluation of cytotoxicity and antitumour activities, Pharmakeftiki, 23, 1
Coulidiati, 2015, Distinct effects of novel naphtoquinone-based triazoles in human leukaemic cell lines, J. Pharm. Pharmacol., 67, 1682, 10.1111/jphp.12474
Prasad, 2018, Novel menadione hybrids: synthesis, anticancer activity, and cell-based studies, Chem. Biol. Drug Des., 91, 220, 10.1111/cbdd.13073
Gholampour, 2019, Click chemistry-assisted synthesis of novel aminonaphthoquinone-1,2,3-triazole hybrids and investigation of their cytotoxicity and cancer cell cycle alterations, Bioorg. Med., 88, e102967, 10.1016/j.bioorg.2019.102967
Costa, 2018, Synthesis and evaluation of the cytotoxic activity of furanaphthoquinones tethered to 1H-1,2,3-triazoles in Caco-2, Calu-3, MDA-MB231 cells, Eur. J. Med. Chem., 156, 524, 10.1016/j.ejmech.2018.07.018
Chipoline, 2018, Synthesis and cytotoxic evaluation of 1H-1,2,3-triazol-1-ylmethyl-2,3-dihydronaphtho[1.2-b]furan-4,5-diones, Ann. Acad. Bras. Ciencias, 90, 1027, 10.1590/0001-3765201820170698
da Cruz, 2016, Synthesis and antitumor activity of selenium-containing quinone-based triazoles possessing two redox centres, and their mechanistic insights, Eur. J. Med. Chem., 122, 1, 10.1016/j.ejmech.2016.06.019
Bahia, 2016, Molecular hybridization as a powerful tool towards multitarget quinoidal systems: synthesis, trypanocidal and antitumor activities of naphthoquinone-based 5-iodo-1,4-disubstituted-, 1,4- and 1,5-disubstituted-1,2,3-triazoles, MedChemComm, 7, 1555, 10.1039/C6MD00216A
Gupta, 2013, Current status on development of steroids as anticancer agents, J. Steroid Biochem. Mol. Biol., 137, 242, 10.1016/j.jsbmb.2013.05.011
Navacchia, 2016, NO photoreleaser-deoxyadenosine and -bile acid derivative bioconjugates as novel potential photochemotherapeutics, ACS Med. Chem. Lett., 7, 939, 10.1021/acsmedchemlett.6b00257
Minorics, 2018, Steroidal anticancer agents: an overview of estradiol-related compounds, Anti Cancer Agents Med. Chem., 18, 652, 10.2174/1871520617666171114111721
Najr, 2015, Discovery and development of Galeterone (TOK-001 or VN/124-1) for the treatment of all stages of prostate cancer, J. Med. Chem., 58, 2077, 10.1021/jm501239f
Rahman, 2017, Synthesis and biological evaluation of novel 3-O-tethered triazoles of diosgenin as potent antiproliferative agents, Steroids, 118, 1, 10.1016/j.steroids.2016.11.003
Mernyak, 2015, Synthesis of trans-16-triazolyl-13a-methyl-17-estradiol diastereomers and the effects of structural modifications on their in vitro antiproliferative activities, J. Steroid Biochem. Mol. Biol., 150, 123, 10.1016/j.jsbmb.2015.04.001
Zuco, 2002, Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells, Cancer Lett., 175, 17, 10.1016/S0304-3835(01)00718-2
Chrobak, 2019, New phosphate derivatives of betulin as anticancer agents: synthesis, crystal structure, and molecular docking study, Bioorg. Chem., 87, 613, 10.1016/j.bioorg.2019.03.060
Grishko, 2017, Preparation of novel ring-A fused azole derivatives of betulin and evaluation of their cytotoxicity, Eur. J. Med. Chem., 125, 629, 10.1016/j.ejmech.2016.09.065
Sidova, 2017, Cytotoxic conjugates of betulinic acid and substituted triazoles prepared by Huisgen Cycloaddition from 30-azidoderivatives, PLoS One, 12, e0717621, 10.1371/journal.pone.0171621
Suman, 2017, Synthesis and cytotoxicity of Baylis-Hillman template derived betulinic acid-triazole conjugates, Tetrahedron, 73, 4214, 10.1016/j.tet.2016.11.056
Khan, 2016, A novel triazole derivative of betulinic acid induces extrinsic and intrinsic apoptosis in human leukemia HL-60 cells, Eur. J. Med. Chem., 108, 104, 10.1016/j.ejmech.2015.11.018
Dangroo, 2017, A convergent synthesis of novel alkyne-azide cycloaddition congeners of betulinic acid as potent cytotoxic agent, Steroids, 123, 1, 10.1016/j.steroids.2017.04.002
Chakraborty, 2015, Synthesis and biological evaluation of a novel betulinic acid derivative as an inducer of apoptosis in human colon carcinoma cells (HT-29), Eur. J. Med. Chem., 102, 93, 10.1016/j.ejmech.2015.07.035
Bebenek, 2017, Novel triazole hybrids of betulin: synthesis and biological activity profile, Molecules, 22, e1876, 10.3390/molecules22111876
Majeed, 2016, PI3K target based novel cyano derivative of betulinic acid induces its signalling inhibition by down-regulation of pGSK3b and cyclin D1 and potentially checks cancer cell proliferation, Mol. Carcinog., 55, 964, 10.1002/mc.22339
Dalidovich, 2019, New azole derivatives of [17(20)E]-21-norpregnene: synthesis and inhibition of prostate carcinoma cell growth, Steroids, 147, 10, 10.1016/j.steroids.2018.08.004
Wei, 2015, A library of 1,2,3-triazole-substituted oleanolic acid derivatives as anticancer agents: design, synthesis, and biological evaluation, Org. Biomol. Chem., 13, 1507, 10.1039/C4OB01605J
Mohamed, 2015, Cu (I) catalyzed alkyne-azide 1,3-dipolar cycloaddition (CuAAC): synthesis of 17a-[1-(substituted phenyl)-1,2,3-triazol-4-yl]-19-nortestosterone-17b-yl acetates targeting progestational and antiproliferative activities, Eur. J. Med. Chem., 97, 75, 10.1016/j.ejmech.2015.04.045
Khaybullin, 2015, Synthesis and anticancer evaluation of complex unsaturated isosteviol derived triazole conjugates, Future Med. Chem., 7, 2419, 10.4155/fmc.15.158
Chouaib, 2016, Microwave-assisted synthesis, anti-inflammatory and anti-proliferative activities of new maslinic acid derivatives bearing 1,5- and 1,4-disubstituted triazoles, J. Enzym. Inhib. Med. Chem., 31, 130, 10.1080/14756366.2016.1193733
Anandkumar, 2017, Synthesis and anticancer activity of bile acid dendrimers with triazole as bridging unit through click chemistry, Steroids, 125, 37, 10.1016/j.steroids.2017.06.007
Pinho, 2015, Glycosylation in cancer: mechanisms and clinical implications, Nat. Rev. Cancer, 15, 540, 10.1038/nrc3982
Feng, 2013, Bifunctional unnatural sialic acids for dual metabolic labeling of cell-surface sialylated glycans, J. Am. Chem. Soc., 135, 9244, 10.1021/ja402326z
Amdouni, 2017, In vitro and in vivo evaluation of fully substituted (5-(3-ethoxy-3-oxopropynyl)-4-(ethoxycarbonyl)-1,2,3-triazolyl-glycosides as original nucleoside analogs to circumvent resistance in myeloid malignancies, J. Med. Chem., 60, 1523, 10.1021/acs.jmedchem.6b01803
Li, 2018, Synthesis, antitumor activity evaluation and mechanistic study of novel hederacolchiside A1 derivatives bearing an aryl triazole moiety, Bioorg. Med. Chem., 26, 4025, 10.1016/j.bmc.2018.06.026
Petrova, 2015, Antimicrobial and cytotoxic activities of 1,2,3-triazole-sucrose derivatives, Carbohydr. Res., 417, 66, 10.1016/j.carres.2015.09.003
Zayas, 2015, Strain promoted click chemistry of 2- or 8-azidopurine and 5-azidopyrimidine nucleosides and 8-azidoadenosine triphosphate with cyclooctynes. Application to living cell fluorescent imaging, Bioconjug. Chem., 26, 1519, 10.1021/acs.bioconjchem.5b00300
Boens, 2015, Synthesis and biological evaluations of click-generated nitrogen mustards, Nucleosides Nucleotides Nucleic Acids, 34, 500, 10.1080/15257770.2015.1017580
Massaro, 2016, Chemical and pharmaceutical evaluation of the relationship between triazole linkers and pore size on cyclodextrin-calixarene nanosponges used as carriers for natural drugs, RSC Adv., 6, 50858, 10.1039/C6RA06143E
Wang, 2018, Synthesis and antiproliferative activity of flavonoid triazolyl glycosides, Heterocycl. Commun., 24, 119, 10.1515/hc-2017-0241
Igual, 2019, Novel glucopyranoside C2-derived 1,2,3-triazoles displaying selective inhibition of O-GlcNAcase (OGA), Carbohydr. Res., 471, 43, 10.1016/j.carres.2018.10.007
Hsieh, 2018, A triazole-conjugated benzoxazone induces reactive oxygen species and promotes autophagic apoptosis in human lung cancer cells, Apoptosis, 23, 1, 10.1007/s10495-017-1432-9
Su, 2017, Using gene expression database to uncover biology functions of 1,4-disubstituted 1,2,3-triazole analogues synthesized via a copper (I)-catalyzed reaction, Eur. J. Med. Chem., 132, 90, 10.1016/j.ejmech.2017.03.034
Nagavelli, 2016, Synthesis, characterization and biological evaluation of 7-substituted-4-((1-aryl-1H-1,2,3-triazol-4-yl)methyl)-2H-benzo[b][1,4]oxazin-3(4H)-ones as anticancer agents, Med. Chem. Res., 25, 1781, 10.1007/s00044-016-1616-9
Shaikh, 2016, Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent, Bioorg. Med. Chem. Lett, 26, 561, 10.1016/j.bmcl.2015.11.071
Narsimha, 2018, Microwave-assisted Cu-catalyzed C-C bond formation: one-pot synthesis of fully substituted 1,2,3-triazoles using nonsymmetrical iodoalkynes and their biological evaluation, Chem. Heterocycl. Comp., 54, 1161, 10.1007/s10593-019-02408-6
Reichart, 2016, Cyclization of a cell-penetrating peptide via click-chemistry increases proteolytic resistance and improves drug delivery, J. Pept. Sci., 22, 421, 10.1002/psc.2885
Cumming, 2016, Synthesis of a simplified triazole analogue of pateamine, A. Org. Biol. Chem., 14, 5117
Hernandez-Vazquez, 2018, Cytotoxic activity and structure-activity relationship of triazole-containing bis(aryl ether) macrocycles, ChemMedChem, 13, 1193, 10.1002/cmdc.201800075
Tapadar, 2015, A structure-activity relationship of non-peptide macrocyclic histone deacetylase inhibitors and their anti-proliferative and anti-inflammatory activities, Bioorg. Med. Chem., 23, 7543, 10.1016/j.bmc.2015.10.045
Huang, 2018, Synthesis and anticancer activity of novel rapamycin C-28 containing triazole moiety compounds, Arch. Pharm., 351, e1800123, 10.1002/ardp.201800123
Xie, 2016, Synthesis of rapamycin derivatives containing the triazole moiety used as potential mTOR-targeted anticancer agents, Arch. Pharm. Chem. Life Sci., 349, 428, 10.1002/ardp.201500457
Hou, 2019, Click chemistry-based synthesis and cytotoxic activity evaluation of 4α-triazole acetate podophyllotoxin derivatives, Chem. Biol. Drug Des., 93, 473, 10.1111/cbdd.13436
Vishnuvardhan, 2017, Click chemistry-assisted synthesis of triazolo linked podophyllotoxin conjugates as tubulin polymerization inhibitors, MedChemComm, 8, 1817, 10.1039/C7MD00273D
Kumari, 2018, Computer-assisted drug designing of triazole derivative of noscapine as tubulin-binding anticancer drug, Asian J. Pharmaceut. Clin. Res., 11, 69, 10.22159/ajpcr.2018.v11s2.28586
Reddy, 2018, 4α-Amidotriazole linked podophyllotoxin congeners: DNA topoisomerase-IIa inhibition and potential anticancer agents for prostate cancer, Eur. J. Med. Chem., 144, 595, 10.1016/j.ejmech.2017.12.050
Zi, 2018, Synthesis and anticancer activity of dimeric podophyllotoxin derivatives, Drug Des. Dev. Ther., 12, 3393, 10.2147/DDDT.S167382
Poornima, 2017, Novel Gomisin B analogues as potential cytotoxic agents: design, synthesis, biological evaluation and docking studies, Eur. J. Med. Chem., 139, 441, 10.1016/j.ejmech.2017.07.076
Mareddy, 2017, 1,2,3-Triazole-nimesulide hybrid: their design, synthesis and evaluation as potential anticancer agents, Bioorg. Med. Chem. Lett, 27, 518, 10.1016/j.bmcl.2016.12.030
Slawinski, 2017, Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: synthesis, QSAR study, and metabolic stability, Eur. J. Med. Chem., 132, 236, 10.1016/j.ejmech.2017.03.039
Qader, 2018, Synthesis, characterization and cytotoxic activity of some new 1,2,3-triazole, oxadiazole and aza-β-lactam derivatives, Orient. J. Chem., 34, 2350, 10.13005/ojc/340516
Swaroop, 2018, Novel 1,2,3-triazole-functionalized 1,2-benzothiazine 1,1-dioxide derivatives: regioselective synthesis, biological evaluation and docking studies, ChemistrySelect, 3, 2398, 10.1002/slct.201800072
Ke, 2018, Design, synthesis and biological mechanisms research on 1,2,3-triazole derivatives of Jiyuan Oridonin A, Bioorg. Med. Chem., 26, 4761, 10.1016/j.bmc.2017.11.005
Shen, 2019, Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: a novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway, Eur. J. Med. Chem., 173, 15, 10.1016/j.ejmech.2019.04.005
Chandrashekhar, 2016, Novel triazole hybrids of myrrhanone C, a natural polypodane triterpene: synthesis, cytotoxic activity and cell based studies, Eur. J. Med. Chem., 114, 293, 10.1016/j.ejmech.2016.03.013
Poornima, 2015, Novel sesquiterpenes from Schisandra grandiflora: isolation, cytotoxic activity and synthesis of their triazole derivatives using “click” reaction, Eur. J. Med. Chem., 92, 449, 10.1016/j.ejmech.2014.12.040
Chinthala, 2016, Synthesis and cytotoxicity evaluation of novel andrographolide-1,2,3-triazole derivatives, J. Heterocycl. Chem., 53, 1902, 10.1002/jhet.2505
Bozsity, 2017, Mechanism of antiproliferative action of a new D-secoestrone-triazole derivative in cervical cancer cells and its effect on cancer cell motility, J. Steroid Biochem. Mol. Biol., 165, 247, 10.1016/j.jsbmb.2016.06.013
Ding, 2018, Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities, Eur. J. Med. Chem., 156, 216, 10.1016/j.ejmech.2018.06.058
Janganati, 2018, MMB triazole analogs are potent NF-κB inhibitors and anti-cancer agents against both hematological and solid tumor cells, Eur. J. Med. Chem., 157, 562, 10.1016/j.ejmech.2018.08.010
Zaki, 2016, Synthesis and anticancer evaluation of novel 9a-substituted-13-(1,2,3-triazolo)-parthenolides, Tetrahedron Lett., 57, 2591, 10.1016/j.tetlet.2016.04.115
Liu, 2019, Antitumor evaluation of novel phenothiazine derivatives that inhibit migration and tubulin polymerization against gastric cancer MGC-803 cells, Investig. New Drugs, 37, 188, 10.1007/s10637-018-0682-x
Ma, 2017, Design, synthesis and antiproliferative activity of novel phenothiazine-1,2,3-triazole analogues, J. Chem. Res., 41, 696
Zhang, 2018, Antiproliferative phenothiazine hybrids as novel apoptosis inducers against MCF-7 breast cancer, Molecules, 23, e1288, 10.3390/molecules23061288
Li, 2018, Synthesis and biological evaluation of 20-epi-amino-20-deoxysalinomycin derivatives, Eur. J. Med. Chem., 148, 279, 10.1016/j.ejmech.2018.02.004
Huang, 2017, Synthesis and biological evaluation of salinomycin triazole analogues as anticancer agents, Eur. J. Med. Chem., 127, 900, 10.1016/j.ejmech.2016.10.067
Cao, 2019, Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II, Bioorg. Med. Chem., 27, 978, 10.1016/j.bmc.2019.01.041
Li, 2016, Synthesis and anti-tumor activity of novel histone deacetylase inhibitors based on dihydropyridin-2-one scaffold, Acta Pharm. Sin., 51, 1734
Mandalapu, 2016, Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines, Bioorg. Med. Chem. Lett, 26, 4223, 10.1016/j.bmcl.2016.07.053
Saini, 2017, New orally active DNA minor groove binding small molecule CT-1 acts against breast cancer by targeting tumor DNA damage leading to p53-dependent apoptosis, Mol. Carcinog., 56, 1266, 10.1002/mc.22588
Gupta, 2018, Synthesis and biological evaluation of novel bavachinin analogs as anticancer agents, Eur. J. Med. Chem., 145, 511, 10.1016/j.ejmech.2018.01.006
Sudhapriya, 2015, An expedient route to highly diversified [1,2,3]triazolo[1,5-a][1,4]benzodiazepines and their evaluation for antimicrobial, antiproliferative and in silico studies, RSC Adv., 5, 66260, 10.1039/C5RA12497B
Kumar, 2016, Synthesis and biological evaluation of 5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one structural derivatives as anti-cancer and apoptosis inducing agents, Eur. J. Med. Chem., 108, 674, 10.1016/j.ejmech.2015.12.007
Park, 2018, Molecular and functional evaluation of novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound, Oncotarget, 8, 7801, 10.18632/oncotarget.13955
Kuntala, 2015, Novel benzoxepine-1,2,3-triazole hybrids: synthesis and pharmacological evaluation as potential antibacterial and anticancer agents, MedChemComm, 6, 1612, 10.1039/C5MD00224A
Xu, 2016, Discovery of 7-methyl-10-hydroxyhomocamptothecins with 1,2,3-triazole moiety as potent Topoisomerase I inhibitors, Chem. Biol. Drug Des., 88, 398, 10.1111/cbdd.12767
Preya, 2019, The cytotoxic activity of honokiol-triazole derivatives in ovarian cancer cells, Bull. Korean Chem. Soc., 40, 359, 10.1002/bkcs.11691
Nguyen, 2017, 1,2,3-Triazolyl ester of Ketorolac: a “Click Chemistry”-based highly potent PAK1-blocking cancer-killer, Eur. J. Med. Chem., 126, 270, 10.1016/j.ejmech.2016.11.038
Yang, 2016, Synthesis and antitumor activity evaluation of lamiridosin A derivatives, J. Asian Nat. Prod. Res., 18, 26, 10.1080/10286020.2015.1130037
Ali, 2017, Cytotoxic effects of a novel maleimide derivative on epithelial and tumor cells, Bioorg. Chem., 72, 199, 10.1016/j.bioorg.2017.04.013
Samra, 2018, Dual inhibitors of the pro-survival proteins Bcl-2 and Mcl-1 derived from natural compound meiogynin A, Eur. J. Med. Chem., 148, 26, 10.1016/j.ejmech.2018.01.100
Kumar, 2017, Design and synthesis of 1,2,3-triazolo-phenanthrene hybrids as cytotoxic agents, Bioorg. Med. Chem. Lett, 27, 2369, 10.1016/j.bmcl.2017.04.022
Reddy, 2016, Synthesis and biological evaluation of Sapinofuranones A, B and 1,2,3-triazole-Sapinofuranone hybrids as cytotoxic agents, RSC Adv., 6, 101501, 10.1039/C6RA21939J
Aleixo, 2018, Design, synthesis and anticancer biological evaluation of novel 1,4-diaryl-1,2,3-triazole retinoid analogues of tamibarotene (AM80), J. Braz. Chem. Soc., 29, 109
Battula, 2017, Synthesis and biological evaluation of novel thiomorpholine 1,1-dioxide derived 1,2,3-triazole hybrids as potential anticancer agents, ChemistrySelect, 2, 4001, 10.1002/slct.201700524
Battula, 2017, Synthesis and biological evaluation of (N-(3-methoxyphenyl)-4-((aryl-1H-1,2,3-triazol-4-yl)methyl)thiomorpholine-2-carboxamide 1,1-dioxide hybrids as antiproliferative agents, ChemistrySelect, 2, 9595, 10.1002/slct.201701902
Sharma, 2017, Synthesis and biological evaluation of triazole-vanillin molecular hybrids as anti-cancer agents, Curr. Bioact. Compd., 13, 223, 10.2174/1573407213666161128122552
Mo, 2017, Synthesis and anti-tumor activity evaluation of a novel series of dithiocarbamates bearing 1,2,3-triazole and [1-bi(4-fluorophenyl)methyl]piperazine unit, Chin. J. Org. Chem., 37, 1000, 10.6023/cjoc201611039
Mousazadeh, 2017, Study of the cytotoxic and bactericidal effects of sila-substituted thioalkyne and mercaptothione compounds based on 1,2,3-triazole scaffold, Basic Clin. Pharmacol., 121, 390, 10.1111/bcpt.12822
Piao, 2016, The antitumor effect of DYC-279 on human hepatocellular carcinoma HepG2 cells, Pharmacol, 97, 177, 10.1159/000444174
Bonandi, 2017, The 1,2,3-triazole ring as a bioisostere in medicinal chemistry, Drug Discov. Today, 22, 1572, 10.1016/j.drudis.2017.05.014
Giraudo, 2018, 4-Hydroxy-1,2,3-triazole moiety as bioisostere of the carboxylic acid function: a novel scaffold to probe the orthosteric γ-aminobutyric acid receptor binding site, Eur. J. Med. Chem., 158, 311, 10.1016/j.ejmech.2018.08.094
Lauria, 2014, 1,2,3-Triazole in heterocyclic compounds, endowed with biological activity, through 1,3-dipolar cycloadditions, Eur. J. Org. Chem., 2014, 3289, 10.1002/ejoc.201301695
Hou, 2012, The impact of click chemistry in medicinal chemistry, Expert Opin. Drug Discov., 7, 489, 10.1517/17460441.2012.682725
Tian, 2016, Design, synthesis and cytotoxicity of novel dihydroartemisinin-coumarin hybrids via click chemistry, Molecules, 21, e758, 10.3390/molecules21060758
Yu, 2018, Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents, Eur. J. Med. Chem., 151, 434, 10.1016/j.ejmech.2018.04.005
Tien, 2016, Synthesis and cytotoxic evaluation of artemisinin-triazole hybrids, Nat. Prod. Commun., 11, 1789
Zhang, 2016, Design, synthesis and structure-activity relationships of novel chalcone-1,2,3-triazole-azole derivates as antiproliferative agents, Molecules, 21, e653, 10.3390/molecules21050653
Fu, 2016, Synthesis of novel antiproliferative 1,2,3-triazole hybrids using the molecular hybridisation approach, J. Chem. Res., 40, 674
van Truong, 2015, Synthesis and anti-proliferative activity of novel azazerumbone conjugates with chalcones, Bioorg. Med. Chem. Lett, 25, 5182, 10.1016/j.bmcl.2015.09.069
Zhao, 2015, Design, synthesis and anticancer activity of matrine-1H-1,2,3-triazole-chalcone conjugates, Bioorg. Med. Chem. Lett, 25, 2540, 10.1016/j.bmcl.2015.04.051
Singh, 2018, Ferrocenylchalcone-uracil conjugates: synthesis and cytotoxic evaluation, Med. Chem. Res., 27, 1260, 10.1007/s00044-018-2145-5
Ravivarma, 2017, Synthesis, photophysical, electrochemical properties and anticancer, antimicrobial activity of N-n-hexyl-N-phenylanilinochalcone-capped dendrimers, ChemistrySelect, 2, 10167, 10.1002/slct.201701953
Thasnim, 2017, Click-on fluorescent triazolyl coumarin peptidomimetics as inhibitors of human breast cancer cell line MCF-7, New J. Chem., 41, 13483, 10.1039/C7NJ02712E
Chekir, 2018, Design, synthesis and biological evaluation of novel 1,2,3-triazole linked coumarinopyrazole conjugates as potent anticholinesterase, anti-5-lipoxygenase, anti-tyrosinase and anti-cancer agents, Bioorg. Chem., 80, 189, 10.1016/j.bioorg.2018.06.005
Fu, 2017, Discovery of 5,6-diaryl-1,2,4-triazines hybrids as potential apoptosis inducers, Eur. J. Med. Chem., 138, 1076, 10.1016/j.ejmech.2017.07.011
Pathoor, 2018, MCR-Click synthesis, molecular docking and cytotoxicity evaluation of a new series of indole-triazole-coumarin hybrid peptidomimetics, New J. Chem., 41, 6810, 10.1039/C8NJ00032H
Guo, 2018, Design, synthesis and antiproliferative evaluation of novel sulfanilamide-1,2,3-triazole derivatives as tubulin polymerization inhibitors, Investig. New Drugs, 36, 1147, 10.1007/s10637-018-0632-7
Cai, 2015, Novel hybrids from N-hydroxyarylamide and indole ring through click chemistry as histone deacetylase inhibitors with potent antitumor activities, Chin. Chem. Lett., 26, 675, 10.1016/j.cclet.2015.03.015
Kumar, 2016, “Click” reaction mediated synthesis of costunolide and dehydrocostuslactone derivatives and evaluation of their cytotoxic activity, J. Asian Nat. Prod. Res., 18, 1063, 10.1080/10286020.2016.1193012
Nagarsenkar, 2016, Investigation of triazole linked indole and oxindole glycoconjugates as potential anticancer agents: novel Akt/PKB signaling pathway inhibitors, MedChemComm, 7, 646, 10.1039/C5MD00513B
Baltus, 2016, Biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors, Eur. J. Med. Chem., 108, 701, 10.1016/j.ejmech.2015.12.023
Kumar, 2018, 1H-1,2,3-triazole tethered nitroimidazole-isatin conjugates: synthesis, docking, and anti-proliferative evaluation against breast cancer, ACS Omega, 3, 12106, 10.1021/acsomega.8b01513
Huong, 2017, Novel N-hydroxybenzamides incorporating 2-oxoindoline with unexpected potent histone deacetylase inhibitory effects and antitumor cytotoxicity, Bioorg. Chem., 71, 160, 10.1016/j.bioorg.2017.02.002
Dung, 2018, Novel hydroxamic acids incorporating 1-((1H-1,2,3-triazol-4-yl)methyl)-3-hydroxyimino-indolin-2-ones: synthesis, biological evaluation, and SAR analysis, J. Chem. Sci., 130, 63
Sharma, 2015, Triazole linked mono carbonyl curcumin-isatin bifunctional hybrids as novel anti-tubulin agents: design, synthesis, biological evaluation and molecular modeling studies, Bioorg. Med. Chem., 23, 7165, 10.1016/j.bmc.2015.10.013
Singh, 2017, Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: design, synthesis, biological investigation and docking studies, Bioorg. Med. Chem. Lett, 27, 3977, 10.1016/j.bmcl.2017.07.069
Diao, 2019, Design, synthesis, and in vitro anticancer activities of diethylene glycol tethered isatin-1,2,3-triazole-coumarin hybrids, J. Heterocycl. Chem., 56, 1667, 10.1002/jhet.3538
Xu, 2019, Design, synthesis, and evaluation of tetraethylene glycol-tethered isatin-1,2,3-triazole-coumarin hybrids as novel anticancer agents, J. Heterocycl. Chem., 56, 1127, 10.1002/jhet.3475
Fan, 2018, Design, synthesis and antitumor activities of 1,2,3-triazole-diethylene glycol tethered isatin dimers, J. Heterocycl. Chem., 55, 2990, 10.1002/jhet.3330
Xu, 2019, Design, synthesis, and in vitro anti-tumor activities of 1,2,3-triazoletetraethylene glycol tethered heteronuclear bis-Schiff base derivatives of isatin, J. Heterocycl. Chem., 55, 3001
Yu, 2016, Efficient synthesis of new antiproliferative steroidal hybrids using the molecular hybridization approach, Eur. J. Med. Chem., 117, 241, 10.1016/j.ejmech.2016.04.024
Aly, 2015, Click reaction based synthesis, antimicrobial, and cytotoxic activities of new 1,2,3-triazoles, Bioorg. Med. Chem. Lett, 25, 2824, 10.1016/j.bmcl.2015.04.096
Murray, 2019, Synthesis of saccharin-glycoconjugates targeting carbonic anhydrase using a one-pot cyclization/deprotection strategy, Carbohydr. Res., 476, 65, 10.1016/j.carres.2019.03.001
Halay, 2018, Synthesis of triazolylmethyl-linked nucleoside analogs via combination of azidofuranoses with propargylated nucleobases and study on their cytotoxicity, Chem. Heterocycl. Comp., 54, 158, 10.1007/s10593-018-2248-4
Klich, 2016, Synthesis, antibacterial, and anticancer evaluation of novel spiramycin-like conjugates containing C(5) triazole arm, J. Med. Chem., 59, 7963, 10.1021/acs.jmedchem.6b00764
Karayildirim, 2018, Formulation, characterization, cytotoxicity and Salmonella/microsome mutagenicity (Ames) studies of a novel 5-fluorouracil derivative, Saudi Pharm. J., 26, 369, 10.1016/j.jsps.2018.01.004
Dawra, 2016, An efficient method for the synthesis of some chlorinated and heteroatom rich triazole-linked β-lactam glycoconjugates, Tetrahedron, 72, 10.1016/j.tet.2016.10.036
Spivak, 2018, Synthesis of new C-2 triazole-linked analogs of triterpenoid pentacyclic saponins, Chem. Nat. Compd., 54, 315, 10.1007/s10600-018-2331-1
Navacchia, 2017, Rational design of nucleoside-bile acid conjugates incorporating a triazole moiety for anticancer evaluation and SAR exploration, Molecules, 22, e1710, 10.3390/molecules22101710
Mishra, 2019, Design, synthesis and pharmacological evaluation of noscapine glycoconjugates, ChemistrySelect, 4, 2644, 10.1002/slct.201803588
Zi, 2017, Click glycosylation for the synthesis of 1,2,3-triazole-linked picropodophyllotoxin glycoconjugates and their anticancer activity, ChemistrySelect, 2, 5038, 10.1002/slct.201700347
Zi, 2015, Design, synthesis, and cytotoxicity of perbutyrylated glycosides of 4β-triazolopodophyllotoxin derivatives, Molecules, 20, 3255, 10.3390/molecules20023255
Anh, 2017, Synthesis and cytotoxic evaluation of betulin-triazole-AZT hybrids, Nat. Prod. Commun., 12, 1567
Pattnaik, 2017, Synthesis, structural studies, and cytotoxic evaluation of novel ursolic acid hybrids with capabilities to arrest breast cancer cells in mitosis, J. Asian Nat. Prod. Res., 16, 260, 10.1080/10286020.2016.1240169
Jurasek, 2018, Estradiol dimer inhibits tubulin polymerization and microtubule dynamics, J. Steroid Biochem. Mol. Biol., 183, 68, 10.1016/j.jsbmb.2018.05.008
Branco, 2018, A novelthotriazolyl-4-oxoquinoline derivative that selectively controls breast cancer cells survival through the induction of apoptosis, Curr. Top. Med. Chem., 18, 1465, 10.2174/1568026618666180821142458
Krawczyk, 2019, Synthesis of 8-hydroxyquinoline glycoconjugates and preliminary assay of their β1,4-GalT inhibitory and anti-cancer properties, Bioorg. Chem., 84, 326, 10.1016/j.bioorg.2018.11.047
Praveena, 2015, Design of new hybrid template by linking quinoline, triazole and dihydroquinoline pharmacophoric groups: a greener approach to novel polyazaheterocycles as cytotoxic agents, Bioorg. Med. Chem. Lett, 25, 1057, 10.1016/j.bmcl.2015.01.012
Praveena, 2016, Assembly of quinoline, triazole and oxime ether in a single molecular entity: a greener and one-pot synthesis of novel oximes as potential cytotoxic agents, Lett. Drug Des. Discov., 13, 210, 10.2174/1570180812999150819095308
Podolski-Renic, 2017, Ferrocene-cinchona hybrids with triazolyl-chalcone linker act as pro-oxidants and sensitize human cancer cell Lines to paclitaxel, Metallomics, 9, 1132, 10.1039/C7MT00183E
Kandi, 2015, C5-curcuminoid-4-aminoquinoline based molecular hybrids: design, synthesis and mechanistic investigation of anticancer activity, New J. Chem., 39, 224, 10.1039/C4NJ00936C
Ciang, 2018, Design, synthesis and cytotoxic evaluation of 4-anilinoquinazoline-triazole-AZT hybrids as anticancer agents, Nat. Prod. Commun., 13, 1633
Ding, 2017, Synthesis and investigation of novel 6-(1,2,3-triazol-4-yl)-4-aminoquinazolin derivatives possessing hydroxamic acid moiety for cancer therapy, Bioorg. Med. Chem., 25, 27, 10.1016/j.bmc.2016.10.006